Compare EHang Holdings Ltd - ADR (EH) vs Heron Therapeutics Inc (HRTX) Price & Performance

EHang Holdings Limited (EH) trades at $4.14, showing no recent price movement. The stock is technically bearish with moving averages signaling a downtrend. Fundamentally, the company reported a net loss of $275.98 million on $417.98 million revenue in 2025, with negative profit margins and returns. Recent news includes expansion of its Global Fast Track Program to Vietnam but also multiple law firm investigations into investor claims.

The outlook remains challenging with persistent losses and regulatory scrutiny. Investment opportunities hinge on successful commercialization of eVTOL technology, but risks include high cash burn, negative earnings, and legal uncertainties. Analyst consensus is mixed with 20% buy, 40% hold, and 40% sell ratings, reflecting cautious sentiment.

HRTX trades at $0.3967, up 1.72% today, with a bullish technical signal from moving averages but mixed earnings. The company reported a net loss of $20.20 million in 2025, with revenue of $154.90 million, and has a high gross margin of 70.07% but negative profitability metrics. Recent Q2 2026 results missed EPS estimates, though Q4 2025 beat expectations. Analyst consensus is strongly bullish with 17 buy ratings.

The outlook is cautious due to persistent losses and cash burn, but strong analyst support and a low P/S ratio of 0.44 may appeal to value investors. Key risks include ongoing unprofitability and competitive pressures in the biotech sector. Investors should weigh the high institutional optimism against fundamental challenges.